Compare Interactive Brokers Group Inc. Class A Common Stock (IBKR) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Interactive Brokers Group Inc. Class A Common Stock vs Natera Inc. Common Stock — how do they compare? Interactive Brokers Group Inc. Class A Common Stock trades at $84.15 (market cap $38.14B), while Natera Inc. Common Stock trades at $393.93 (market cap $57.03B). The key difference: Natera Inc. Common Stock is the larger of the two by market cap, and Interactive Brokers Group Inc. Class A Common Stock pays a 0.42% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Interactive Brokers Group Inc. Class A Common Stock for 6 Days and Natera Inc. Common Stock for 0 Days on average.
| IBKR | NTRA | |
|---|---|---|
Market Cap | $38.14B | $57.03B |
Volume | 4,556,837 | 1,131,157 |
Sector | Financials | Health |
52-Week High | $98.19 | $425.64 |
52-Week Low | $61.05 | $179.42 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $30.44B | $56.18B |
Dividend Yield | 0.42% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Interactive Brokers (IBKR) trades at $87.49, down 0.46% on the day, with technical indicators showing a bearish bias despite neutral oscillators. The company demonstrates strong fundamentals with revenue growth from $10.22B in 2025 to $11.1B projected for 2026, and net income rising from $984M to $1.1B. Recent earnings beats and expansion into cryptocurrency staking highlight ongoing business development, though valuation multiples appear elevated with a P/E of 34.72.
The outlook remains cautiously optimistic given analyst consensus pointing to 21% upside to the $106.11 price target, balanced by near-term technical weakness and stretched valuations. Key risks include competitive pressures in fintech and market volatility impacting trading volumes, while institutional sentiment shows mixed but generally positive positioning with 47% buy ratings.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Interactive Brokers Group Inc. Class A Common Stock
Interactive Brokers operates an electronic brokerage platform for trading stocks, options, futures, currencies, and other assets. It also provides clearing and custody services.
Read more on IBKR →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
